【手続補正書】
【提出日】平成16年4月2日(2004.4.2)
【手続補正１】
【補正対象書類名】明細書
【補正対象項目名】００９６
【補正方法】変更
【補正の内容】
【００９６】
本発明は例証を挙げて説明されており、使用された用語は限定ではなくむしろ説明のためのものであると意図され、理解されるべきである。上記の開示を考慮すると、本発明の多くの修正または変法が可能である。したがって、添付の特許請求の範囲内で、本発明は具体的に記述された以外の方法で実施され得ることを理解されるべきである。
2004521605.tif 000001
2004521605.tif 000002
2004521605.tif 000003
【配列表】
SEQUENCE LISTING
<110>    REGEN BIOTECH INC.
<120>    METHOD FOR CELL ADHENSION AND WOUND HEALING
<130>    WN-A0204
<140>    JP   2001-583794
<141>    2000-12-08
<150>    KR   2000/25662
<151>    2000-05-13
<160>    21
<170>    KopatentIn 1.71
<210>    1
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_HUMAN
<400>    1
Thr Val Asn Cys Ala Arg Leu Leu Lys Ala Asp His His Ala Thr Asn
1               5                  10                  15 
Gly Val Val His Leu Ile Asp Lys Val Ile
20                  25    
<210>    2
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_PIG
<400>    2
Thr Val Asn Cys Ala Arg Leu Leu Lys Ala Asp His His Ala Thr Asn
1               5                  10                  15 
Gly Val Val His Leu Ile Asp Lys Val Ile
20                  25    
<210>    3
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_CHICK
<400>    3
Thr Val Asn Cys Ala Arg Leu Leu Lys Ala Asp His His Ala Thr Asn
1               5                  10                  15 
Gly Val Val His Val Ile Asp Lys Val Ile
20                  25    
<210>    4
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_HUMAN
<400>    4
Ile Asn Gly Lys Ala Ile Ile Ser Asn Lys Asp Ile Leu Ala Thr Asn
1               5                  10                  15 
Gly Val Ile His Tyr Ile Asp Glu Leu Leu Ile
20                  25        
<210>    5
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_PIG
<400>    5
Ile Asn Gly Lys Pro Ile Ile Ser Asn Lys Asp Val Leu Ala Thr Asn
1               5                  10                  15 
Gly Val Ile His Phe Ile Asp Glu Leu Leu Ile
20                  25        
<210>    6
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_CHICK
<400>    6
Leu Asn Gly Arg Ala Ile Ile Ala Asn Lys Asp Ile Leu Ala Thr Asn
1               5                  10                  15 
Gly Val Val His Phe Val Asn Glu Leu Leu Ile
20                  25        
<210>    7
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    OSF2_HUMAN
<400>    7
Val Asn Gly Ile Lys Met Val Asn Lys Lys Asp Ile Val Thr Asn Asn
1               5                  10                  15 
Gly Val Ile His Leu Ile Asp Gln Val Leu Ile
20                  25        
<210>    8
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    OSF2_MOUSE
<400>    8
Ile Asn Gly Ile Lys Met Val Asn Lys Lys Asp Ile Val Thr Lys Asn
1               5                  10                  15 
Gly Val Ile His Leu Ile Asp Glu Val Leu Ile
20                  25        
<210>    9
<211>    25
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_HUMAN
<400>    9
Val Asn Lys Glu Pro Val Ala Glu Pro Asp Ile Met Ala Thr Asn Gly
1               5                  10                  15 
Val Val His Val Ile Thr Asn Val Leu
20                  25
<210>    10
<211>    25
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_PIG
<400>    10
Val Asn Lys Glu Pro Val Ala Glu Ala Asp Ile Met Ala Thr Asn Gly
1               5                  10                  15 
Val Val His Thr Ile Asn Thr Val Leu
20                  25
<210>    11
<211>    25
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    BIGH3_CHICK
<400>    11
Val Asn Lys Glu Pro Val Ala Glu Ser Asp Ile Met Ala Thr Asn Gly
1               5                  10                  15 
Val Ile His Ala Val Ser Ser Val Leu
20                  25
<210>    12
<211>    28
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    SLL1735 homolog
<400>    12
Val Lys Asn Ala Thr Val Leu Ala Ala Asp Ile Glu Ala Asp Asn Gly
1               5                  10                  15 
Ile Ile His Val Ile Asp Asn Val Ile Leu Met Gly
20                  25            
<210>    13
<211>    28
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    SLL1735
<400>    13
Val Lys Asn Ala Thr Val Ile Ile Pro Asp Ile Glu Ala Asp Asn Gly
1               5                  10                  15 
Ile Ile His Val Ile Asp Asn Val Ile Leu Met Gly
20                  25            
<210>    14
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    SLL1483
<400>    14
Val Asn Lys Ala Thr Val Ile Ser Ala Asp Val Asp Ala Ser Asn Gly
1               5                  10                  15 
Val Ile His Val Ile Asp Gln Val Ile Leu
20                  25    
<210>    15
<211>    25
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    OSF2_HUMAN
<400>    15
Val Asn Glu Leu Lys Ser Lys Glu Ser Asp Ile Met Thr Thr Asn Gly
1               5                  10                  15 
Val Ile His Val Val Asp Lys Leu Leu
20                  25
<210>    16
<211>    25
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    OSF2_MOUSE
<400>    16
Val Asn Glu Leu Lys Ser Lys Glu Ser Asp Ile Met Thr Thr Asn Gly
1               5                  10                  15 
Val Ile His Val Val Asp Lys Leu Leu
20                  25
<210>    17
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    Midline Fasciclin
<400>    17
Ile Asn Asn Leu Ala Lys Ile Ile Asp Ala Asp Ile Met Gly Thr Asn
1               5                  10                  15 
Gly Val Leu His Val Ile Asp Thr Leu Leu
20                  25    
<210>    18
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    HLC-32
<400>    18
Ser Lys Ala Ser Arg Val Ile Leu Arg Asp Ile Pro Thr Thr Asn Gly
1               5                  10                  15 
Val Ile Gln Val Ile Asp Arg Val Ile Leu
20                  25    
<210>    19
<211>    27
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    Midline Fasciclin
<400>    19
Lys Ile Glu Asn Ala Gly Val Thr Lys Cys Asp Val Val Ala Thr Asn
1               5                  10                  15 
Gly Ile Leu His Glu Ile Asn Asp Ile Ile Val
20                  25        
<210>    20
<211>    26
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    HLC-32
<400>    20
Thr Ala Asn Gly Ala Arg Val Val Glu Ala Asp Arg Lys Ala Ser Ser
1               5                  10                  15 
Gly Leu Ile His Val Val Asp Lys Val Ile
20                  25    
<210>    21
<211>    29
<212>    PRT
<213>    Artificial Sequence
<220>
<223>    consensus
<400>    21
Val Asn Asn Ala Ala Arg Val Val Lys Ala Asp Ile His Ala Thr Asn
1               5                  10                  15 
Gly Val Ile His Val Ile Asp Lys Val Leu Ile Met Gly
20                  25